| RS2131957828 |
TSC1
|
Health Risk |
Pathogenic |
Tuberous sclerosis 1, Tuberous sclerosis 1 |
| RS2131958310 |
POLR3A
|
Health Risk |
Likely pathogenic |
Leukodystrophy, hypomyelinating |
| RS2131960043 |
TSC1
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 1, Tuberous sclerosis 1 |
| RS2131961013 |
POLR3A
|
Health Risk |
Pathogenic |
Leukodystrophy, hypomyelinating |
| RS2131961978 |
POLR3A
|
Health Risk |
Pathogenic |
— |
| RS2131963896 |
TSC1
|
Health Risk |
Pathogenic |
Tuberous sclerosis 1, Tuberous sclerosis 1 |
| RS2131964527 |
ZMYND11
|
Health Risk |
Pathogenic |
— |
| RS2131964849 |
CDK5RAP2
|
Health Risk |
Pathogenic |
Microcephaly 3, primary |
| RS2131965369 |
TSC1
|
Health Risk |
Pathogenic |
Tuberous sclerosis 1, Tuberous sclerosis 1 |
| RS2131965427 |
SPTAN1
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, Developmental and epileptic encephalopathy |
| RS2131966858 |
ANK3
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS2131969031 |
SPTAN1
|
Health Risk |
Likely pathogenic |
— |
| RS2131969608 |
ELP1
|
Health Risk |
Likely pathogenic |
— |
| RS2131972800 |
GBA2
|
Health Risk |
Likely pathogenic |
Spastic paraplegia, Spastic paraplegia |
| RS2131972870 |
TSC1
|
Health Risk |
Pathogenic |
Tuberous sclerosis 1, Malignant tumor of urinary bladder |
| RS2131975092 |
TSC1
|
Health Risk |
Pathogenic/Likely pathogenic |
Tuberous sclerosis 1, Tuberous sclerosis 1 |
| RS2131975101 |
ELP1
|
Health Risk |
Likely pathogenic |
— |
| RS2131976201 |
RPS24
|
Health Risk |
Likely pathogenic |
Abnormality of blood and blood-forming tissues, Abnormality of blood and blood-forming tissues |
| RS2131976643 |
RPS24
|
Health Risk |
Likely pathogenic |
Diamond-Blackfan anemia 3, Diamond-Blackfan anemia 3 |
| RS2131977010 |
ZMYND11
|
Health Risk |
Pathogenic |
— |
| RS2131978117 |
ZMYND11
|
Health Risk |
Likely pathogenic |
Intellectual disability, autosomal dominant 30 |
| RS2131979217 |
ZMYND11
|
Health Risk |
Likely pathogenic |
Intellectual disability, autosomal dominant 30 |
| RS2131980225 |
ELP1
|
Health Risk |
Pathogenic |
— |
| RS2131980428 |
TSC1
|
Health Risk |
Pathogenic |
Tuberous sclerosis 1, Tuberous sclerosis 1 |
| RS2131981589 |
ELP1
|
Health Risk |
Likely pathogenic |
— |
| RS2131982095 |
DOCK8
|
Health Risk |
Pathogenic |
Combined immunodeficiency due to DOCK8 deficiency, Combined immunodeficiency due to DOCK8 deficiency |
| RS2131982810 |
ANK3
|
Health Risk |
Pathogenic |
ANK3-related disorder, ANK3-related disorder |
| RS2131982922 |
TSC1
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 1, Hereditary cancer-predisposing syndrome |
| RS2131983329 |
CUX1
|
Health Risk |
Pathogenic/Likely pathogenic |
Neurodevelopmental disorder, Global developmental delay with or without impaired intellectual development |
| RS2131984488 |
ELP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Medulloblastoma, Familial dysautonomia |
| RS2131985466 |
CUX1
|
Health Risk |
Pathogenic |
Global developmental delay with or without impaired intellectual development, Global developmental delay with or without impaired intellectual development |
| RS2131985621 |
SPTAN1
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 5 |
| RS2131988498 |
ELP1
|
Health Risk |
Pathogenic |
— |
| RS2131988821 |
ELP1
|
Health Risk |
Pathogenic/Likely pathogenic |
Medulloblastoma, Familial dysautonomia |
| RS2131991331 |
MYO3A
|
Health Risk |
Likely pathogenic |
Autosomal recessive nonsyndromic hearing loss 30, Autosomal recessive nonsyndromic hearing loss 30 |
| RS2131992124 |
ELP1
|
Health Risk |
Likely pathogenic |
— |
| RS2131992501 |
ELP1
|
Health Risk |
Pathogenic |
— |
| RS2131996846 |
ELP1
|
Health Risk |
Pathogenic |
— |
| RS2132003172 |
ELP1
|
Health Risk |
Pathogenic |
— |
| RS2132003711 |
ELP1
|
Health Risk |
Pathogenic |
— |
| RS2132004661 |
TSC1
|
Health Risk |
Pathogenic |
Tuberous sclerosis 1, Tuberous sclerosis 1 |
| RS2132007757 |
ELP1
|
Health Risk |
Pathogenic |
— |
| RS2132010730 |
LRSAM1
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease axonal type 2P, Charcot-Marie-Tooth disease axonal type 2P |
| RS2132013543 |
ELP1
|
Health Risk |
Pathogenic |
— |
| RS2132013740 |
ELP1
|
Health Risk |
Pathogenic |
— |
| RS2132013817 |
ELP1
|
Health Risk |
Pathogenic/Likely pathogenic |
Medulloblastoma, Medulloblastoma |
| RS2132014128 |
ELP1
|
Health Risk |
Likely pathogenic |
— |
| RS2132014132 |
ELP1
|
Health Risk |
Likely pathogenic |
— |
| RS2132016792 |
ELP1
|
Health Risk |
Pathogenic |
— |
| RS2132016798 |
ELP1
|
Health Risk |
Pathogenic |
— |
| RS2132017050 |
ELP1
|
Health Risk |
Pathogenic |
— |
| RS2132017099 |
ELP1
|
Health Risk |
Likely pathogenic |
Familial dysautonomia, Familial dysautonomia |
| RS2132018294 |
FKTN
|
Health Risk |
Pathogenic |
Walker-Warburg congenital muscular dystrophy, Walker-Warburg congenital muscular dystrophy |
| RS2132023620 |
CDH23
|
Health Risk |
Pathogenic |
— |
| RS2132025021 |
ELP1
|
Health Risk |
Likely pathogenic |
Familial dysautonomia, Familial dysautonomia |
| RS2132025166 |
ELP1
|
Health Risk |
Pathogenic |
— |
| RS2132026515 |
MUSK
|
Health Risk |
Likely pathogenic |
Congenital myasthenic syndrome 9, Fetal akinesia deformation sequence 1 |
| RS2132032720 |
ZMIZ1
|
Health Risk |
Pathogenic |
— |
| RS2132032860 |
ZMIZ1
|
Health Risk |
Pathogenic |
— |
| RS2132032937 |
ZMIZ1
|
Health Risk |
Likely pathogenic |
— |
| RS2132034522 |
DNAI1
|
Health Risk |
Likely pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS2132036795 |
MYO3A
|
Health Risk |
Pathogenic |
Autosomal recessive nonsyndromic hearing loss 30, Autosomal recessive nonsyndromic hearing loss 30 |
| RS2132037242 |
ZMIZ1
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder with dysmorphic facies and distal skeletal anomalies, Neurodevelopmental disorder with dysmorphic facies and distal skeletal anomalies |
| RS2132037844 |
ZMIZ1
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder with dysmorphic facies and distal skeletal anomalies, Neurodevelopmental disorder with dysmorphic facies and distal skeletal anomalies |
| RS2132039347 |
ZNF462
|
Health Risk |
Likely pathogenic |
Weiss-Kruszka syndrome, Weiss-Kruszka syndrome |
| RS2132043448 |
PEX2
|
Health Risk |
Pathogenic |
— |
| RS2132043567 |
PEX2
|
Health Risk |
Pathogenic/Likely pathogenic |
Peroxisome biogenesis disorder 5A (Zellweger), Peroxisome biogenesis disorder 5A (Zellweger) |
| RS2132043667 |
PEX2
|
Health Risk |
Pathogenic |
Peroxisome biogenesis disorder 5A (Zellweger), Peroxisome biogenesis disorder 5A (Zellweger) |
| RS2132043724 |
PEX2
|
Health Risk |
Pathogenic |
Peroxisome biogenesis disorder 5A (Zellweger), Peroxisome biogenesis disorder 5A (Zellweger) |
| RS2132043781 |
PEX2
|
Health Risk |
Pathogenic |
Peroxisome biogenesis disorder 5A (Zellweger), Peroxisome biogenesis disorder 5A (Zellweger) |
| RS2132043966 |
PEX2
|
Health Risk |
Pathogenic |
Peroxisome biogenesis disorder 5A (Zellweger), Peroxisome biogenesis disorder 5A (Zellweger) |
| RS2132044032 |
PEX2
|
Health Risk |
Pathogenic |
Peroxisome biogenesis disorder 5A (Zellweger), Peroxisome biogenesis disorder 5A (Zellweger) |
| RS2132044079 |
PEX2
|
Health Risk |
Pathogenic |
Peroxisome biogenesis disorder 5A (Zellweger), Peroxisome biogenesis disorder 5A (Zellweger) |
| RS2132044384 |
PEX2
|
Health Risk |
Pathogenic |
Peroxisome biogenesis disorder 5A (Zellweger), Peroxisome biogenesis disorder 5A (Zellweger) |
| RS2132044757 |
PEX2
|
Health Risk |
Pathogenic/Likely pathogenic |
Peroxisome biogenesis disorder 5A (Zellweger), Peroxisome biogenesis disorder 5A (Zellweger) |
| RS2132045027 |
PEX2
|
Health Risk |
Pathogenic |
Peroxisome biogenesis disorder 5A (Zellweger), Peroxisome biogenesis disorder 5A (Zellweger) |
| RS2132045183 |
SFTPA2
|
Health Risk |
Pathogenic |
Interstitial lung disease 2, Interstitial lung disease 2 |
| RS2132045372 |
ZMYND11
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal dominant 30 |
| RS2132045613 |
ELP1
|
Health Risk |
Pathogenic/Likely pathogenic |
Familial dysautonomia, Medulloblastoma |
| RS2132045760 |
ZMYND11
|
Health Risk |
Likely pathogenic |
Intellectual disability, autosomal dominant 30 |
| RS2132046225 |
ZMYND11
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal dominant 30 |
| RS2132046601 |
ZMYND11
|
Health Risk |
Pathogenic |
— |
| RS2132046635 |
SFTPA2
|
Health Risk |
Pathogenic |
Interstitial lung disease 2, Interstitial lung disease 2 |
| RS2132052954 |
ELP1
|
Health Risk |
Pathogenic |
— |
| RS2132057373 |
DNAI1
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS2132057423 |
DNAI1
|
Health Risk |
Pathogenic/Likely pathogenic |
Primary ciliary dyskinesia, Kartagener syndrome |
| RS2132057443 |
DNAI1
|
Health Risk |
Pathogenic/Likely pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS2132059492 |
ELN
|
Health Risk |
Pathogenic |
Supravalvar aortic stenosis, Supravalvar aortic stenosis |
| RS2132060982 |
DNAI1
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS2132061817 |
DNAI1
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS2132063305 |
DNAI1
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS2132063794 |
LRSAM1
|
Health Risk |
Likely pathogenic |
Charcot-Marie-Tooth disease axonal type 2P, Charcot-Marie-Tooth disease axonal type 2P |
| RS2132065095 |
CUX1
|
Health Risk |
Likely pathogenic |
Global developmental delay with or without impaired intellectual development, Global developmental delay with or without impaired intellectual development |
| RS2132065273 |
DNAI1
|
Health Risk |
Likely pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS2132065290 |
DNAI1
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS2132066003 |
NPR2
|
Health Risk |
Pathogenic |
Acromesomelic dysplasia 1, Maroteaux type |
| RS2132066161 |
NPR2
|
Health Risk |
Pathogenic |
Acromesomelic dysplasia 1, Maroteaux type |
| RS2132066800 |
NPR2
|
Health Risk |
Conflicting classifications of pathogenicity |
Acromesomelic dysplasia 1, Maroteaux type |
| RS2132066904 |
NPR2
|
Health Risk |
Pathogenic |
Acromesomelic dysplasia 1, Maroteaux type |
| RS2132068542 |
NPR2
|
Health Risk |
Likely pathogenic |
— |